Benjamin Paluch

Stock Analyst at Roth MKM

(2.52)

# 2,266

Out of 4,905 analysts

3

Total ratings

66.67%

Success rate

13.59%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Benjamin Paluch

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CGON CG Oncology	Initiates: Buy	$65	$26.75	+142.99%	1	Aug 27, 2024
	REPL Replimune Group	Initiates: Buy	$17	$12.09	+40.61%	1	Aug 27, 2024
	GNLX Genelux	Initiates: Buy	$10	$3.33	+200.30%	1	Aug 27, 2024

CG Oncology

Aug 27, 2024

Initiates: Buy

Price Target: $65

Current: $26.75

Upside: +142.99%

Replimune Group

Aug 27, 2024

Initiates: Buy

Price Target: $17

Current: $12.09

Upside: +40.61%

Genelux

Aug 27, 2024

Initiates: Buy

Price Target: $10

Current: $3.33

Upside: +200.30%